Close Menu

UMass

NEW YORK (GenomeWeb) – A US District Court late last month threw out a lawsuit filed by a former University of Massachusetts researcher against the Carnegie Institution of Washington over inventorship of seminal intellectual property related to the discovery of RNA interference.

NEW YORK (GenomeWeb) – In Nature Genetics, an American- and Finnish-led team described the apparent effects of an EGLN1 mutation that's been linked to high-altitude adaptations in the absence o

NEW YORK (GenomeWeb News) – The Massachusetts Life Sciences Center has provided $8 million in funding to support continued development of the Center for Personalized Cancer Therapy, a joint initiative between the University of Massachusetts Boston and the Dana-Farber/Harvard Cancer Center (DF/HCC

Australian expressed RNAi firm Benitec Biopharma provided an update on its research and development activities late last month, reporting that it remains on track to move its lead drug candidate, the hepatitis C therapy TT-034, into the clinic as early as this month.

NEW YORK (GenomeWeb News) – A team from the Universities of Massachusetts and Pennsylvania is finding new contributors to genetically complex common diseases or traits using a statistical strategy that harvests locus-level information from existing genome-wide association study data.

RNAi researcher Anastasia Khvorova has joined the RNA Therapeutics Institute at the University of Massachusetts Medical School as a professor of molecular medicine.

NEW YORK (GenomeWeb News) – There are hundreds of genomic regions that are uniquely regulated in the human brain as compared to other primates, an international team of researchers reporte

The University of Utah this month took steps to keep its RNAi intellectual property lawsuit on track after the defendants in the case sought a stay of proceedings, arguing that discovery in the litigation should proceed while certain jurisdictional issues are resolved.

NEW YORK (GenomeWeb News) – A new study is adding heft to the notion that cytoskeletal pathway alterations can spur amyotrophic lateral sclerosis, or ALS, commonly known as Lou Gehrig's Disease.

Silence Therapeutics said this week that it plans to raise as much as £5.7 million ($8.8 million) through the issuance of up to around 940 million new ordinary shares.

Pages

The US National Institutes of Health's All of Us project awarded $4.6 million to the company Color to develop a genetic counseling resource for the program.

The Times of India reports on a pilot study that used genomic testing to determine whether patients had drug-resistant tuberculosis.

New guidelines say that more women may benefit from genetic testing for hereditary breast or ovarian cancer, according to the Los Angeles Times.

In Cell this week: small proteins identified among human microbiome, role for tumor microbes in pancreatic cancer survival, and more.